International breast health care; implementation science focusing on low- and middle-income countries; oncoplastic surgical techniques for breast conservation therapy; lobular carcinoma in situ (LCIS); Paget's disease of the breast; phyllodes tumors of the breast; management of the high-risk breast cancer patient; and neoadjuvant therapy for breast cancer.
Studies of host (e.g., germline genetic, environmental, and lifestyle exposures) and primary tumor tissue (e.g., methylome, transcriptome) characteristics that either influence risk of developing prostate cancer or disease aggressiveness resulting in metastatic-lethal patient outcomes.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.